Related Experiment Video
Updated: Mar 18, 2026
10:44
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
13.9K
A Prospectus of Tenomodulin
Vesselin P Alexandrov1, Samir I Naimov2
1Department of Medical Biology, Faculty of Medicine, Medical University of Plovdiv, Plovdiv, Bulgaria
Folia Medica
|July 8, 2016
Summary
Tenomodulin, a protein regulating tendon growth, is crucial for tenocyte differentiation and development. Its gene polymorphisms link to various diseases, highlighting its broad biological significance.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Tenomodulin (TNMD) is a type II transmembrane glycoprotein.
- It is predominantly expressed in dense connective tissues like tendons and ligaments.
- TNMD acts as a marker for tenocyte differentiation and regulates tendon development.
Purpose of the Study:
- To elucidate the role of tenomodulin in tendon biology.
- To explore the association of tenomodulin gene polymorphisms with various health conditions.
- To investigate the potential therapeutic applications of tenomodulin.
Main Methods:
- Analysis of tenomodulin structure and expression patterns.
- Genetic association studies of tenomodulin gene polymorphisms.
- Review of existing literature on tenomodulin's functions and implications.
Main Results:
- Tenomodulin is a 40-45 kDa cell surface protein involved in cell adhesion and morphology.
- It inhibits angiogenesis and is vital for tenocyte proliferation and tendon development.
- Gene polymorphisms in tenomodulin are linked to obesity, diabetes, and Alzheimer's disease.
Conclusions:
- Tenomodulin is a key regulator of tendon homeostasis and development.
- Its involvement extends to various physiological processes and disease risks.
- Tenomodulin holds promise for therapeutic interventions in tendon repair and other conditions.
Related Concept Videos
01:28Preclinical Development: Overview
6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
212
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
212
01:24Glucagon-like Receptor Agonists
1.2K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.2K
01:16Therapeutic Drug Monitoring: Overview and Classification
493
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
493
01:02Prescription, Nonprescription and Orphan Drugs
1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
01:11Clinical Trials: Overview
5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K